Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study

Abstract Background Effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus long-acting insulins (LAIs) on preventing progressive chronic kidney outcomes is uncertain for type 2 diabetes (T2D) patients requiring intensive glycemic control. This study aimed to evaluate comparativ...

Descrición completa

Detalles Bibliográficos

Principais autores:	Zi-Yang Peng, Chun-Ting Yang, Wei-Hung Lin, Wen-Yu Yao, Huang-Tz Ou, Shihchen Kuo
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-10-01
Series:	Cardiovascular Diabetology
Assuntos:	Chronic kidney outcomes Intensive glycemic control GLP-1 receptor agonists Long-acting insulins
Acceso en liña:	https://doi.org/10.1186/s12933-023-01991-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!